ACUC — AcuCort AB Share News
0.000.00%
Last trade - 00:00- SEK114.17m
- SEK103.80m
- SEK0.69m
Brief: AcuCort Signs Its First Commercial Agreement For Zeqmelit
Brief: Acucort AB Acucort Receives Marketing Authorization For Drug Zeqmelit By Norwegian Medicines Agency
Brief: Acucort Receives Marketing Authorization For The Drug Zeqmelit By The Danish Medicines Agency
Brief: AcuCort Is Granted Sme Status By The European Medicines Agency, EMA
Brief: Acucort Is Exempted From The Application Fee By The U.S. Food And Drug Administration
Brief: AcuCort Is Exempted From Application Fee By U.S. Food And Drug Administration
Brief: AcuCort Granted Trademark Protection In U.S. For Drug Isicort
Brief: Acucort's Drug Isicort Approved For Treatment Of COVID-19
Brief: Acucort Q3 Net Loss Narrows To SEK 1.6 Million
Brief: Acucort Is Granted A Patent In China
Brief: AcuCort Granted Patent In China
Brief: AcuCort Gets Market Approval From Swedish Medical Products Agency For Drug ISICORT
Brief: AcuCort Q2 Net Loss Narrows To SEK 2.1 Million
Brief: Acucort Names Jonas Jönmark New CEO
Brief: AcuCort Interim CEO Ann Gidner To Leave Co
Brief: AcuCort Comments On Status Update Regarding Second US Patent Application
Brief: AcuCort Says Carl Johan Fredin Not To Assume CEO Position
Brief: AcuCort Q1 Net Loss Widens To SEK 2.1 Million
Brief: Acucort Appoints Carl Johan Fredin As New CEO